If your CD term is almost up, missing your bank’s instruction deadline could really cost you—locking you into a low APY and a new term you may not be ready for.
Introduction Electronic health (E-Health) technologies present a valuable opportunity to enhance healthcare access and outcomes for Indigenous populations by addressing persistent, often structurally ...
Former CFO Christina Ross discusses her transition to founder and CEO of Cube, raising capital, modernizing FP&A, and how the ...
Why Ramp, Robinhood, Bilt, Circle, Addi, and Plaid are among Fast Company’s Most Innovative Companies of 2026.
CHARLOTTE, N.C. - Sealed Air Corporation (NYSE:SEE) announced that stockholders voted in favor of all proposals at a special meeting held today, including approval of the company’s pending acquisition ...
CD&R added 1,689,758 shares of Resideo; estimated trade size ~$62.53 million based on quarterly average price. Quarter-end position value decreased by $47.74 million, reflecting both trading and ...
Covetrus, a private-equity-backed tech company for veterinary practices, is in preliminary talks to purchase Cencora Inc.'s veterinary business, according to a Bloomberg report from late Friday. CD&R, ...
Certificate of deposit (CD) rates are expected to plateau through the first half of 2026, offering a narrow window for savers to lock in yields before the Federal Reserve potentially cuts rates. While ...
Clayton Dubilier & Rice and TPG Inc. are in talks with private credit firms including Blue Owl Capital Inc. to line up at least $2.5 billion of debt for Covetrus, a technology company for veterinary ...
Clayton Dubilier & Rice is seeking $26 billion for its latest flagship private equity fund, an ambitious target that would count among the industry’s largest-ever fundraises. CD&R has begun ...
US-based packaging producer Sealed Air has confirmed that the 30-day 'go-shop' period linked to its agreed sale to funds affiliated with Clayton, Dubilier & Rice (CD&R) has expired. The update follows ...
Sealed Air's (SEE) sale to CD&R could see some investor pushback as the price is likely below expectations, according to a Wolfe Research analyst. "We sense that the deal value is below most buy-side ...